#begin document (en_1509.txt); part 000
en_1509.txt	0	0	Europe	NNP	(TOP(FRAG(NP*)	-	-	-	-	*	(0)
en_1509.txt	0	1	\	SYM	(X(X*)	-	-	-	-	*	-
en_1509.txt	0	2	u0027s	NNS	(NP*	-	-	-	-	*	-
en_1509.txt	0	3	Bad	NNP	*	-	-	-	-	*	-
en_1509.txt	0	4	Lungs	NNS	*))))	-	-	-	-	*	-

en_1509.txt	0	0	Respiratory	JJ	(TOP(S(S(NP*	-	-	-	-	*	(1
en_1509.txt	0	1	disease	NN	*)	-	-	-	-	*	1)
en_1509.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	4	world	NN	*	-	-	-	-	*	-
en_1509.txt	0	5	'	POS	*)	-	-	-	-	*	-
en_1509.txt	0	6	s	NN	*	-	-	-	-	*	-
en_1509.txt	0	7	leading	VBG	*	-	-	-	-	*	-
en_1509.txt	0	8	killer	NN	*)))	-	-	-	-	*	-
en_1509.txt	0	9	,	,	*	-	-	-	-	*	-
en_1509.txt	0	10	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	11	it	PRP	(S(NP*)	-	-	-	-	*	(1)
en_1509.txt	0	12	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	13	on	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	14	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	15	rise	NN	*))))	-	-	-	-	*	-
en_1509.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	According	VBG	(TOP(S(PP*	-	-	-	-	*	-
en_1509.txt	0	1	to	TO	(PP*	-	-	-	-	*	-
en_1509.txt	0	2	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	3	World	NNP	*	-	-	-	-	*	-
en_1509.txt	0	4	Health	NNP	*	-	-	-	-	*	-
en_1509.txt	0	5	Organization	NNP	*)	-	-	-	-	*	-
en_1509.txt	0	6	,	,	*	-	-	-	-	*	-
en_1509.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	8	all	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	9	50.5	CD	(QP*	-	-	-	-	*	-
en_1509.txt	0	10	million	CD	*)	-	-	-	-	*	-
en_1509.txt	0	11	deaths	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	12	recorded	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	13	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	14	1990	CD	(NP*))))))))	-	-	-	-	*	-
en_1509.txt	0	15	,	,	*	-	-	-	-	*	-
en_1509.txt	0	16	9.4	CD	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	17	million	CD	*))	-	-	-	-	*	-
en_1509.txt	0	18	were	VBD	(VP*	-	-	-	-	*	-
en_1509.txt	0	19	due	JJ	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	20	to	TO	(PP*	-	-	-	-	*	-
en_1509.txt	0	21	respiratory	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	22	diseases	NNS	*))))	-	-	-	-	*	-
en_1509.txt	0	23	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	By	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1509.txt	0	1	2020	CD	(NP*))	-	-	-	-	*	-
en_1509.txt	0	2	,	,	*	-	-	-	-	*	-
en_1509.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	4	68	CD	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	5	million	CD	*)	-	-	-	-	*	-
en_1509.txt	0	6	deaths	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	7	,	,	*	-	-	-	-	*	-
en_1509.txt	0	8	11.9	CD	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	9	million	CD	*))	-	-	-	-	*	-
en_1509.txt	0	10	will	MD	(VP*	-	-	-	-	*	-
en_1509.txt	0	11	be	VB	(VP*	-	-	-	-	*	-
en_1509.txt	0	12	caused	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	13	by	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	14	Chronic	NNP	(NP(NP*	-	-	-	-	*	(2
en_1509.txt	0	15	Obstructive	NNP	*	-	-	-	-	*	-
en_1509.txt	0	16	Pulmonary	NNP	*	-	-	-	-	*	-
en_1509.txt	0	17	Disease	NNP	*)	-	-	-	-	*	-
en_1509.txt	0	18	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1509.txt	0	19	COPD	NNP	(NP*)	-	-	-	-	*	-
en_1509.txt	0	20	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_1509.txt	0	21	,	,	*	-	-	-	-	*	-
en_1509.txt	0	22	pneumonia	NN	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	23	,	,	*	-	-	-	-	*	-
en_1509.txt	0	24	lung	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	25	cancer	NN	*)	-	-	-	-	*	-
en_1509.txt	0	26	,	,	*	-	-	-	-	*	-
en_1509.txt	0	27	or	CC	*	-	-	-	-	*	-
en_1509.txt	0	28	tuberculosis	NN	(NP*)))))))	-	-	-	-	*	2)
en_1509.txt	0	29	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Europe	NNP	(TOP(S(NP*)	-	-	-	-	*	(0)
en_1509.txt	0	1	performs	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	2	little	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_1509.txt	0	3	better	JJR	*)	-	-	-	-	*	-
en_1509.txt	0	4	than	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	6	rest	NN	*)	-	-	-	-	*	-
en_1509.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	8	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	9	world	NN	*))))))	-	-	-	-	*	-
en_1509.txt	0	10	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Respiratory	JJ	(TOP(S(NP*	-	-	-	-	*	(3
en_1509.txt	0	1	diseases	NNS	*)	-	-	-	-	*	3)
en_1509.txt	0	2	rank	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	second	NN	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	4	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1509.txt	0	5	after	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	6	cardiovascular	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	7	diseases	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	8	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_1509.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	10	terms	NNS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	12	mortality	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	13	,	,	*	-	-	-	-	*	-
en_1509.txt	0	14	incidence	NN	*	-	-	-	-	*	-
en_1509.txt	0	15	,	,	*	-	-	-	-	*	-
en_1509.txt	0	16	prevalence	NN	*	-	-	-	-	*	-
en_1509.txt	0	17	,	,	*	-	-	-	-	*	-
en_1509.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	19	costs	NNS	*)))))	-	-	-	-	*	-
en_1509.txt	0	20	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1509.txt	0	1	some	DT	(NP*	-	-	-	-	*	(4
en_1509.txt	0	2	countries	NNS	*))	-	-	-	-	*	4)
en_1509.txt	0	3	,	,	(PRN*	-	-	-	-	*	-
en_1509.txt	0	4	such	JJ	(PP*	-	-	-	-	*	-
en_1509.txt	0	5	as	IN	*	-	-	-	-	*	-
en_1509.txt	0	6	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	7	United	NNP	*	-	-	-	-	*	-
en_1509.txt	0	8	Kingdom	NNP	*))	-	-	-	-	*	-
en_1509.txt	0	9	,	,	*)	-	-	-	-	*	-
en_1509.txt	0	10	they	PRP	(NP*)	-	-	-	-	*	(3)
en_1509.txt	0	11	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	12	already	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	13	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	14	leading	VBG	*	-	-	-	-	*	-
en_1509.txt	0	15	killer	NN	*))	-	-	-	-	*	-
en_1509.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	The	DT	(TOP(S(NP(NP(NP*	-	-	-	-	*	(5
en_1509.txt	0	1	European	NNP	*	-	-	-	-	*	-
en_1509.txt	0	2	White	NNP	*	-	-	-	-	*	-
en_1509.txt	0	3	Book	NNP	*)	-	-	-	-	*	-
en_1509.txt	0	4	on	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	5	Lung	NNP	(NP*	-	-	-	-	*	(2
en_1509.txt	0	6	Disease	NNP	*)))	-	-	-	-	*	2)
en_1509.txt	0	7	,	,	*	-	-	-	-	*	-
en_1509.txt	0	8	published	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	10	2003	CD	(NP*))	-	-	-	-	*	-
en_1509.txt	0	11	by	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	12	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	13	European	NNP	*	-	-	-	-	*	-
en_1509.txt	0	14	Respiratory	NNP	*	-	-	-	-	*	-
en_1509.txt	0	15	Society	NNP	*)	-	-	-	-	*	-
en_1509.txt	0	16	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	17	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	18	European	NNP	*	-	-	-	-	*	-
en_1509.txt	0	19	Lung	NNP	*	-	-	-	-	*	-
en_1509.txt	0	20	Foundation	NNP	*))))	-	-	-	-	*	-
en_1509.txt	0	21	,	,	*)	-	-	-	-	*	5)
en_1509.txt	0	22	produced	VBD	(VP*	-	-	-	-	*	-
en_1509.txt	0	23	epidemiological	JJ	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	24	data	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	25	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	26	the	DT	(NP(NP*	-	-	-	-	*	(6
en_1509.txt	0	27	full	JJ	*	-	-	-	-	*	-
en_1509.txt	0	28	spectrum	NN	*)	-	-	-	-	*	-
en_1509.txt	0	29	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	30	lung	NN	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	31	diseases	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	32	collected	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	33	from	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	34	all	DT	(NP*	-	-	-	-	*	(4
en_1509.txt	0	35	European	JJ	*	-	-	-	-	*	-
en_1509.txt	0	36	countries	NNS	*))	-	-	-	-	*	4)
en_1509.txt	0	37	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	38	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	39	first	JJ	*	-	-	-	-	*	-
en_1509.txt	0	40	time	NN	*)))))))))	-	-	-	-	*	6)
en_1509.txt	0	41	.	.	*	-	-	-	-	*	-
en_1509.txt	0	42	It	PRP	(S(NP*)	-	-	-	-	*	(6)
en_1509.txt	0	43	provides	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	44	a	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	45	detailed	VBN	*	-	-	-	-	*	-
en_1509.txt	0	46	overview	NN	*)	-	-	-	-	*	-
en_1509.txt	0	47	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	48	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	49	evolution	NN	*)	-	-	-	-	*	-
en_1509.txt	0	50	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	51	lung	NN	(NP*	-	-	-	-	*	(7
en_1509.txt	0	52	diseases	NNS	*))	-	-	-	-	*	7)
en_1509.txt	0	53	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	54	Europe	NNP	(NP*))	-	-	-	-	*	(0)
en_1509.txt	0	55	,	,	*	-	-	-	-	*	-
en_1509.txt	0	56	including	VBG	(PP*	-	-	-	-	*	-
en_1509.txt	0	57	data	NNS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	58	on	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	59	morbidity	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	60	,	,	*	-	-	-	-	*	-
en_1509.txt	0	61	mortality	NN	*	-	-	-	-	*	-
en_1509.txt	0	62	,	,	*	-	-	-	-	*	-
en_1509.txt	0	63	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	64	costs	NNS	*)))))))))	-	-	-	-	*	-
en_1509.txt	0	65	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	We	PRP	(TOP(S(NP*)	-	-	-	-	*	-
en_1509.txt	0	1	have	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	2	learned	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	a	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	4	great	JJ	*	-	-	-	-	*	-
en_1509.txt	0	5	deal	NN	*)	-	-	-	-	*	-
en_1509.txt	0	6	from	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	the	DT	(NP*	-	-	-	-	*	(5
en_1509.txt	0	8	White	NNP	*	-	-	-	-	*	-
en_1509.txt	0	9	Book	NNP	*)))))	-	-	-	-	*	5)
en_1509.txt	0	10	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1509.txt	0	1	example	NN	(NP*))	-	-	-	-	*	-
en_1509.txt	0	2	,	,	*	-	-	-	-	*	-
en_1509.txt	0	3	lung	NN	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	4	cancer	NN	*	-	-	-	-	*	-
en_1509.txt	0	5	mortality	NN	*	-	-	-	-	*	-
en_1509.txt	0	6	rates	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	7	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	8	males	NNS	(NP*)))	-	-	-	-	*	-
en_1509.txt	0	9	fell	VBD	(VP(VP*	-	-	-	-	*	-
en_1509.txt	0	10	slightly	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	11	between	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	12	1960	CD	(NP*	-	-	-	-	*	-
en_1509.txt	0	13	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	14	1989	CD	*))	-	-	-	-	*	-
en_1509.txt	0	15	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	16	some	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	17	Western	JJ	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	18	European	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	19	countries	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	20	,	,	*	-	-	-	-	*	-
en_1509.txt	0	21	such	JJ	(PP*	-	-	-	-	*	-
en_1509.txt	0	22	as	IN	*	-	-	-	-	*	-
en_1509.txt	0	23	Norway	NNP	(NP*	-	-	-	-	*	-
en_1509.txt	0	24	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	25	Switzerland	NNP	*)))))	-	-	-	-	*	-
en_1509.txt	0	26	,	,	*	-	-	-	-	*	-
en_1509.txt	0	27	but	CC	*	-	-	-	-	*	-
en_1509.txt	0	28	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	29	still	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	30	rising	VBG	(VP*	-	-	-	-	*	-
en_1509.txt	0	31	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	32	females	NNS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	33	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	34	almost	RB	(NP*	-	-	-	-	*	-
en_1509.txt	0	35	all	DT	*	-	-	-	-	*	-
en_1509.txt	0	36	European	JJ	*	-	-	-	-	*	-
en_1509.txt	0	37	countries	NNS	*)))))))	-	-	-	-	*	-
en_1509.txt	0	38	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	The	DT	(TOP(S(NP(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	1	prevalence	NN	*)	-	-	-	-	*	-
en_1509.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	3	COPD	NNP	(NP*)))	-	-	-	-	*	(8)
en_1509.txt	0	4	,	,	*	-	-	-	-	*	-
en_1509.txt	0	5	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1509.txt	0	6	is	VBZ	(S(VP*	-	-	-	-	*	-
en_1509.txt	0	7	diagnosed	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	8	mainly	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	10	smokers	NNS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	11	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	12	former	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	13	smokers	NNS	*)))))))	-	-	-	-	*	-
en_1509.txt	0	14	,	,	*)	-	-	-	-	*	-
en_1509.txt	0	15	ranges	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	16	from	IN	(PP(PP*	-	-	-	-	*	-
en_1509.txt	0	17	2,000	CD	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	18	per	IN	*	-	-	-	-	*	-
en_1509.txt	0	19	100,000	CD	*)	-	-	-	-	*	-
en_1509.txt	0	20	inhabitants	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	21	to	TO	(PP*	-	-	-	-	*	-
en_1509.txt	0	22	more	JJR	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	23	than	IN	*	-	-	-	-	*	-
en_1509.txt	0	24	10,000	CD	*))))	-	-	-	-	*	-
en_1509.txt	0	25	,	,	*	-	-	-	-	*	-
en_1509.txt	0	26	with	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	27	mortality	NN	(S(NP*	-	-	-	-	*	-
en_1509.txt	0	28	rates	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	29	varying	VBG	(VP*	-	-	-	-	*	-
en_1509.txt	0	30	between	IN	(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	31	25	CD	*	-	-	-	-	*	-
en_1509.txt	0	32	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	33	75	CD	*))	-	-	-	-	*	-
en_1509.txt	0	34	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	35	100,000	CD	(NP*)))))))	-	-	-	-	*	-
en_1509.txt	0	36	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Lung	NNP	(TOP(S(NP*	-	-	-	-	*	(7
en_1509.txt	0	1	diseases	NNS	*)	-	-	-	-	*	7)
en_1509.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	not	RB	(ADVP*	-	-	-	-	*	-
en_1509.txt	0	4	just	RB	*)	-	-	-	-	*	-
en_1509.txt	0	5	related	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	6	to	TO	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	smoking	NN	(NP*))))	-	-	-	-	*	-
en_1509.txt	0	8	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Genetic	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1509.txt	0	1	influences	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	2	,	,	*	-	-	-	-	*	-
en_1509.txt	0	3	along	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	4	with	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	5	nutritional	JJ	(NP(ADJP*	-	-	-	-	*	-
en_1509.txt	0	6	,	,	*	-	-	-	-	*	-
en_1509.txt	0	7	environmental	JJ	*	-	-	-	-	*	-
en_1509.txt	0	8	,	,	*	-	-	-	-	*	-
en_1509.txt	0	9	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	10	poverty-related	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	11	factors	NNS	*)))	-	-	-	-	*	-
en_1509.txt	0	12	,	,	*	-	-	-	-	*	-
en_1509.txt	0	13	play	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	14	key	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	15	roles	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1509.txt	0	1	COPD	NNP	(NP*)	-	-	-	-	*	(8)
en_1509.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	predicted	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	4	to	TO	(S(VP*	-	-	-	-	*	-
en_1509.txt	0	5	increase	VB	(VP*	-	-	-	-	*	-
en_1509.txt	0	6	as	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	a	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	8	cause	NN	*)	-	-	-	-	*	-
en_1509.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	10	death	NN	(NP*))))	-	-	-	-	*	-
en_1509.txt	0	11	,	,	*	-	-	-	-	*	-
en_1509.txt	0	12	along	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	13	with	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	14	lung	NN	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	15	cancer	NN	*)	-	-	-	-	*	-
en_1509.txt	0	16	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	17	TB	NN	(NP*)))))))))	-	-	-	-	*	-
en_1509.txt	0	18	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Epidemiological	JJ	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	1	data	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	2	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	3	TB	NN	(NP*)))	-	-	-	-	*	-
en_1509.txt	0	4	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	5	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	6	most	RBS	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	7	complete	JJ	*))	-	-	-	-	*	-
en_1509.txt	0	8	,	,	*	-	-	-	-	*	-
en_1509.txt	0	9	due	JJ	(PP*	-	-	-	-	*	-
en_1509.txt	0	10	to	TO	*	-	-	-	-	*	-
en_1509.txt	0	11	a	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	12	surveillance	NN	*	-	-	-	-	*	-
en_1509.txt	0	13	system	NN	*)	-	-	-	-	*	-
en_1509.txt	0	14	developed	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	15	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	16	all	DT	(NP*	-	-	-	-	*	(4
en_1509.txt	0	17	European	JJ	*	-	-	-	-	*	-
en_1509.txt	0	18	countries	NNS	*))))))	-	-	-	-	*	4)
en_1509.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Whereas	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_1509.txt	0	1	TB	NNS	(S(NP(NP(NP*	-	-	-	-	*	(9
en_1509.txt	0	2	'	POS	*)	-	-	-	-	*	-
en_1509.txt	0	3	s	JJ	*	-	-	-	-	*	-
en_1509.txt	0	4	incidence	NN	*	-	-	-	-	*	-
en_1509.txt	0	5	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	6	mortality	NN	*	-	-	-	-	*	-
en_1509.txt	0	7	rates	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	8	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	9	Western	NNP	(NP*	-	-	-	-	*	-
en_1509.txt	0	10	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	11	Central	NNP	(NP*	-	-	-	-	*	-
en_1509.txt	0	12	Europe	NNP	*))))	-	-	-	-	*	9)
en_1509.txt	0	13	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	14	stable	JJ	(UCP(ADJP*)	-	-	-	-	*	-
en_1509.txt	0	15	or	CC	*	-	-	-	-	*	-
en_1509.txt	0	16	declining	VBG	(VP*)))))	-	-	-	-	*	-
en_1509.txt	0	17	,	,	*	-	-	-	-	*	-
en_1509.txt	0	18	they	PRP	(NP*)	-	-	-	-	*	(9)
en_1509.txt	0	19	have	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	20	increased	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	21	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	22	Eastern	NNP	(NP*	-	-	-	-	*	(0
en_1509.txt	0	23	Europe	NNP	*))	-	-	-	-	*	0)
en_1509.txt	0	24	during	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	25	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	26	last	JJ	*	-	-	-	-	*	-
en_1509.txt	0	27	decade	NN	*))	-	-	-	-	*	-
en_1509.txt	0	28	,	,	*	-	-	-	-	*	-
en_1509.txt	0	29	due	JJ	(PP*	-	-	-	-	*	-
en_1509.txt	0	30	to	TO	*	-	-	-	-	*	-
en_1509.txt	0	31	deteriorating	VBG	(NP*	-	-	-	-	*	-
en_1509.txt	0	32	health	NN	*	-	-	-	-	*	-
en_1509.txt	0	33	systems	NNS	*))))	-	-	-	-	*	-
en_1509.txt	0	34	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Pneumonia	NN	(TOP(S(NP*)	-	-	-	-	*	-
en_1509.txt	0	1	will	MD	(VP*	-	-	-	-	*	-
en_1509.txt	0	2	remain	VB	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	an	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	4	important	JJ	*	-	-	-	-	*	-
en_1509.txt	0	5	cause	NN	*)	-	-	-	-	*	-
en_1509.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	death	NN	(NP*)))	-	-	-	-	*	-
en_1509.txt	0	8	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	9	Europe	NNP	(NP*))	-	-	-	-	*	(0)
en_1509.txt	0	10	,	,	*	-	-	-	-	*	-
en_1509.txt	0	11	with	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	12	incidence	NN	(S(NP*)	-	-	-	-	*	-
en_1509.txt	0	13	currently	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	14	ranging	VBG	(VP*	-	-	-	-	*	-
en_1509.txt	0	15	from	IN	(PP(PP*	-	-	-	-	*	-
en_1509.txt	0	16	250	CD	(NP*))	-	-	-	-	*	-
en_1509.txt	0	17	to	TO	(PP*	-	-	-	-	*	-
en_1509.txt	0	18	more	JJR	(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	19	than	IN	*	-	-	-	-	*	-
en_1509.txt	0	20	1,000	CD	*))	-	-	-	-	*	-
en_1509.txt	0	21	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	22	100,000	CD	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	23	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	24	mortality	NN	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	25	from	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	26	15	CD	(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	27	to	TO	*	-	-	-	-	*	-
en_1509.txt	0	28	45	CD	*))	-	-	-	-	*	-
en_1509.txt	0	29	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	30	100,000	CD	(NP*)))))))))))))))	-	-	-	-	*	-
en_1509.txt	0	31	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Asthma	NN	(TOP(S(NP*)	-	-	-	-	*	-
en_1509.txt	0	1	has	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	2	become	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	increasingly	RB	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	4	prevalent	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	6	recent	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	7	decades	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	8	,	,	*	-	-	-	-	*	-
en_1509.txt	0	9	affecting	VBG	(S(VP*	-	-	-	-	*	-
en_1509.txt	0	10	2-20	CD	(NP(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	11	%	NN	*)	-	-	-	-	*	-
en_1509.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	13	children	NNS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	15	Europe	NNP	(NP*)))))	-	-	-	-	*	(0)
en_1509.txt	0	16	,	,	*	-	-	-	-	*	-
en_1509.txt	0	17	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	18	between	IN	(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	19	5	CD	*	-	-	-	-	*	-
en_1509.txt	0	20	%	NN	*	-	-	-	-	*	-
en_1509.txt	0	21	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	22	10	CD	*	-	-	-	-	*	-
en_1509.txt	0	23	%	NN	*))	-	-	-	-	*	-
en_1509.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	25	adults	NNS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	26	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	27	Western	NNP	(NP*	-	-	-	-	*	(10
en_1509.txt	0	28	Europe	NNP	*))))))))))	-	-	-	-	*	10)
en_1509.txt	0	29	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Reported	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1509.txt	0	1	mortality	NN	*	-	-	-	-	*	-
en_1509.txt	0	2	rates	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	3	vary	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	4	widely	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	5	,	,	*	-	-	-	-	*	-
en_1509.txt	0	6	the	DT	(S(NP*	-	-	-	-	*	-
en_1509.txt	0	7	highest	JJS	*)	-	-	-	-	*	-
en_1509.txt	0	8	being	VBG	(VP*	-	-	-	-	*	-
en_1509.txt	0	9	more	JJR	(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	10	than	IN	*	-	-	-	-	*	-
en_1509.txt	0	11	eight	CD	*	-	-	-	-	*	-
en_1509.txt	0	12	per	IN	*	-	-	-	-	*	-
en_1509.txt	0	13	100,000	CD	*))	-	-	-	-	*	-
en_1509.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	15	Portugal	NNP	(NP*))))))	-	-	-	-	*	-
en_1509.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Data	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	1	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	2	other	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	3	respiratory	JJ	*	-	-	-	-	*	-
en_1509.txt	0	4	diseases	NNS	*)))	-	-	-	-	*	-
en_1509.txt	0	5	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	6	scarce	JJ	(ADJP*))	-	-	-	-	*	-
en_1509.txt	0	7	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Interstitial	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1509.txt	0	1	lung	NN	*	-	-	-	-	*	-
en_1509.txt	0	2	diseases	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	3	vary	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	4	considerably	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	6	incidence	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	7	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	8	prevalence	NN	*)))	-	-	-	-	*	-
en_1509.txt	0	9	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	1	prevalence	NN	*)	-	-	-	-	*	-
en_1509.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	3	sleep-related	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	4	diseases	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	5	,	,	*	-	-	-	-	*	-
en_1509.txt	0	6	for	IN	(SBAR(WHPP*	-	-	-	-	*	-
en_1509.txt	0	7	which	WDT	(WHNP*))	-	-	-	-	*	-
en_1509.txt	0	8	data	NNS	(S(NP*)	-	-	-	-	*	-
en_1509.txt	0	9	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	10	available	JJ	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	11	only	RB	(PP*	-	-	-	-	*	-
en_1509.txt	0	12	from	IN	*	-	-	-	-	*	-
en_1509.txt	0	13	some	DT	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	15	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	16	Western	JJ	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	17	European	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	18	countries	NNS	*))))))))	-	-	-	-	*	-
en_1509.txt	0	19	,	,	*)	-	-	-	-	*	-
en_1509.txt	0	20	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	21	less	JJR	(NP(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	22	than	IN	*	-	-	-	-	*	-
en_1509.txt	0	23	1,000	CD	*))	-	-	-	-	*	-
en_1509.txt	0	24	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	25	100,000	CD	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	26	inhabitants	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	27	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	28	France	NNP	(NP*)))))	-	-	-	-	*	-
en_1509.txt	0	29	,	,	*	-	-	-	-	*	-
en_1509.txt	0	30	but	CC	*	-	-	-	-	*	-
en_1509.txt	0	31	more	JJR	(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	32	than	IN	*	-	-	-	-	*	-
en_1509.txt	0	33	5,000	CD	*))	-	-	-	-	*	-
en_1509.txt	0	34	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	35	100,000	CD	(NP*))	-	-	-	-	*	-
en_1509.txt	0	36	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	37	Sweden	NNP	(NP*)))))	-	-	-	-	*	-
en_1509.txt	0	38	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Available	JJ	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	1	data	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	2	on	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	4	incidence	NN	*)	-	-	-	-	*	-
en_1509.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	6	cystic	NN	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	7	fibrosis	NN	*)	-	-	-	-	*	-
en_1509.txt	0	8	,	,	*	-	-	-	-	*	-
en_1509.txt	0	9	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	10	most	RBS	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	11	important	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	12	hereditary	JJ	*	-	-	-	-	*	-
en_1509.txt	0	13	lung	NN	*	-	-	-	-	*	-
en_1509.txt	0	14	disease	NN	*)	-	-	-	-	*	-
en_1509.txt	0	15	,	,	*)))))	-	-	-	-	*	-
en_1509.txt	0	16	indicate	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	17	a	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	18	range	NN	*)	-	-	-	-	*	-
en_1509.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	20	between	IN	(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	21	five	CD	*	-	-	-	-	*	-
en_1509.txt	0	22	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	23	ten	NN	*))	-	-	-	-	*	-
en_1509.txt	0	24	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	25	100,000	CD	(NP*))))))	-	-	-	-	*	-
en_1509.txt	0	26	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Where	WRB	(TOP(SBARQ(WHADVP*)	-	-	-	-	*	-
en_1509.txt	0	1	does	VBZ	(SQ*	-	-	-	-	*	-
en_1509.txt	0	2	respiratory	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	3	disease	NN	*)	-	-	-	-	*	-
en_1509.txt	0	4	kill	VB	(VP*	-	-	-	-	*	-
en_1509.txt	0	5	most	RBS	(ADVP*	-	-	-	-	*	-
en_1509.txt	0	6	often	RB	*)))	-	-	-	-	*	-
en_1509.txt	0	7	?	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	According	VBG	(TOP(S(PP*	-	-	-	-	*	-
en_1509.txt	0	1	to	TO	(PP*	-	-	-	-	*	-
en_1509.txt	0	2	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	3	data	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	4	collected	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	6	the	DT	(NP*	-	-	-	-	*	(5
en_1509.txt	0	7	White	NNP	*	-	-	-	-	*	-
en_1509.txt	0	8	Book	NNP	*))))))	-	-	-	-	*	5)
en_1509.txt	0	9	,	,	*	-	-	-	-	*	-
en_1509.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	11	age-standardized	JJ	*	-	-	-	-	*	-
en_1509.txt	0	12	mortality	NN	*	-	-	-	-	*	-
en_1509.txt	0	13	rate	NN	*)	-	-	-	-	*	-
en_1509.txt	0	14	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	15	100,000	CD	(NP*	-	-	-	-	*	-
en_1509.txt	0	16	inhabitants	NNS	*)))	-	-	-	-	*	-
en_1509.txt	0	17	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	18	highest	JJS	(ADJP*)	-	-	-	-	*	-
en_1509.txt	0	19	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	20	Kyrgyzstan	NNP	(NP(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	21	,	,	*	-	-	-	-	*	-
en_1509.txt	0	22	at	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	23	165	CD	(NP*))	-	-	-	-	*	-
en_1509.txt	0	24	,	,	*)	-	-	-	-	*	-
en_1509.txt	0	25	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	26	lowest	JJS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	27	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	28	Austria	NNP	(NP*))	-	-	-	-	*	(11)
en_1509.txt	0	29	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1509.txt	0	30	30	CD	(NP*)	-	-	-	-	*	-
en_1509.txt	0	31	-RRB-	-RRB-	*)))))	-	-	-	-	*	-
en_1509.txt	0	32	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(12
en_1509.txt	0	1	European	JJ	*	-	-	-	-	*	-
en_1509.txt	0	2	average	NN	*)	-	-	-	-	*	12)
en_1509.txt	0	3	stands	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	4	at	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	5	65	CD	(NP*))	-	-	-	-	*	-
en_1509.txt	0	6	,	,	*	-	-	-	-	*	-
en_1509.txt	0	7	while	IN	(SBAR*	-	-	-	-	*	-
en_1509.txt	0	8	the	DT	(S(NP*	-	-	-	-	*	(12
en_1509.txt	0	9	European	NNP	*	-	-	-	-	*	-
en_1509.txt	0	10	Union	NNP	*	-	-	-	-	*	-
en_1509.txt	0	11	average	NN	*)	-	-	-	-	*	12)
en_1509.txt	0	12	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	13	57	CD	(NP*)))))	-	-	-	-	*	-
en_1509.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Ireland	NNP	(TOP(S(NP(NP*)	-	-	-	-	*	(13)
en_1509.txt	0	1	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	2	the	DT	(NP*	-	-	-	-	*	(14
en_1509.txt	0	3	UK	NNP	*))	-	-	-	-	*	14)
en_1509.txt	0	4	suffer	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	5	some	DT	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	8	highest	JJS	*	-	-	-	-	*	-
en_1509.txt	0	9	rates	NNS	*)))	-	-	-	-	*	-
en_1509.txt	0	10	-	:	(PRN*	-	-	-	-	*	-
en_1509.txt	0	11	120	CD	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	12	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	13	105	CD	*)	-	-	-	-	*	-
en_1509.txt	0	14	,	,	*	-	-	-	-	*	-
en_1509.txt	0	15	respectively	RB	(ADVP*))	-	-	-	-	*	-
en_1509.txt	0	16	-	:	*)	-	-	-	-	*	-
en_1509.txt	0	17	whereas	IN	(SBAR*	-	-	-	-	*	-
en_1509.txt	0	18	other	JJ	(S(NP*	-	-	-	-	*	-
en_1509.txt	0	19	Western	JJ	(ADJP(ADJP*	-	-	-	-	*	-
en_1509.txt	0	20	European	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	21	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	22	most	RBS	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	23	Central	JJ	*))	-	-	-	-	*	-
en_1509.txt	0	24	European	JJ	*	-	-	-	-	*	-
en_1509.txt	0	25	countries	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	26	remain	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	27	below	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	28	the	DT	(NP*	-	-	-	-	*	(12
en_1509.txt	0	29	average	NN	*))))))	-	-	-	-	*	12)
en_1509.txt	0	30	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	As	IN	(TOP(SINV(PP*	-	-	-	-	*	-
en_1509.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	2	incidence	NN	*)	-	-	-	-	*	-
en_1509.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	4	lung	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	5	disease	NN	*	-	-	-	-	*	-
en_1509.txt	0	6	rises	NNS	*))))	-	-	-	-	*	-
en_1509.txt	0	7	,	,	*	-	-	-	-	*	-
en_1509.txt	0	8	so	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	9	will	MD	(VP*)	-	-	-	-	*	-
en_1509.txt	0	10	its	PRP$	(NP*	-	-	-	-	*	-
en_1509.txt	0	11	costs	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	12	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	1	total	JJ	*	-	-	-	-	*	-
en_1509.txt	0	2	annual	JJ	*	-	-	-	-	*	-
en_1509.txt	0	3	financial	JJ	*	-	-	-	-	*	-
en_1509.txt	0	4	burden	NN	*)	-	-	-	-	*	-
en_1509.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	6	respiratory	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	7	diseases	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	8	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	9	Europe	NNP	(NP*)))	-	-	-	-	*	(0)
en_1509.txt	0	10	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	11	currently	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	12	approximately	RB	(NP(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	13	€	SYM	(QP*	-	-	-	-	*	-
en_1509.txt	0	14	100	CD	*	-	-	-	-	*	-
en_1509.txt	0	15	billion	CD	*))	-	-	-	-	*	-
en_1509.txt	0	16	,	,	*	-	-	-	-	*	-
en_1509.txt	0	17	with	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	18	COPD	NNP	(S(NP*)	-	-	-	-	*	(8)
en_1509.txt	0	19	accounting	VBG	(VP*	-	-	-	-	*	-
en_1509.txt	0	20	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	21	almost	RB	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	22	half	NN	*)	-	-	-	-	*	-
en_1509.txt	0	23	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	24	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	25	total	NN	*))))))))	-	-	-	-	*	-
en_1509.txt	0	26	,	,	*	-	-	-	-	*	-
en_1509.txt	0	27	followed	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	28	by	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	29	asthma	NN	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	30	,	,	*	-	-	-	-	*	-
en_1509.txt	0	31	pneumonia	NN	(NP*)	-	-	-	-	*	-
en_1509.txt	0	32	,	,	*	-	-	-	-	*	-
en_1509.txt	0	33	lung	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	34	cancer	NN	*)	-	-	-	-	*	-
en_1509.txt	0	35	,	,	*	-	-	-	-	*	-
en_1509.txt	0	36	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	37	TB	NN	(NP*))))))	-	-	-	-	*	-
en_1509.txt	0	38	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Inpatient	NN	(TOP(S(NP*	-	-	-	-	*	-
en_1509.txt	0	1	care	NN	*)	-	-	-	-	*	-
en_1509.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	just	RB	(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	5	tip	NN	*)	-	-	-	-	*	-
en_1509.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	8	iceberg	NN	*)))	-	-	-	-	*	-
en_1509.txt	0	9	,	,	*	-	-	-	-	*	-
en_1509.txt	0	10	amounting	VBG	(S(VP*	-	-	-	-	*	-
en_1509.txt	0	11	to	TO	(PP*	-	-	-	-	*	-
en_1509.txt	0	12	€	SYM	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	13	17.8	CD	*	-	-	-	-	*	-
en_1509.txt	0	14	billion	CD	*)))	-	-	-	-	*	-
en_1509.txt	0	15	annually	RB	(ADVP*))))	-	-	-	-	*	-
en_1509.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Surprisingly	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1509.txt	0	1	,	,	*	-	-	-	-	*	-
en_1509.txt	0	2	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	3	annual	JJ	*	-	-	-	-	*	-
en_1509.txt	0	4	number	NN	*)	-	-	-	-	*	-
en_1509.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	6	hospital	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	7	days	NNS	*)))	-	-	-	-	*	-
en_1509.txt	0	8	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	9	higher	JJR	(ADJP(ADJP*	-	-	-	-	*	-
en_1509.txt	0	10	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	11	Western	NNP	(NP*	-	-	-	-	*	(10
en_1509.txt	0	12	Europe	NNP	*)))	-	-	-	-	*	10)
en_1509.txt	0	13	than	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	15	Central	NNP	(NP(NP(NP*)	-	-	-	-	*	(15)
en_1509.txt	0	16	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	17	Eastern	NNP	(NP*	-	-	-	-	*	(0
en_1509.txt	0	18	Europe	NNP	*))	-	-	-	-	*	0)
en_1509.txt	0	19	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1509.txt	0	20	11.1	CD	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	21	versus	CC	*	-	-	-	-	*	-
en_1509.txt	0	22	7.2	CD	*)	-	-	-	-	*	-
en_1509.txt	0	23	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	24	100,000	CD	(NP*	-	-	-	-	*	-
en_1509.txt	0	25	population	NN	*)))	-	-	-	-	*	-
en_1509.txt	0	26	-RRB-	-RRB-	*)))))	-	-	-	-	*	-
en_1509.txt	0	27	,	,	*	-	-	-	-	*	-
en_1509.txt	0	28	while	IN	(SBAR*	-	-	-	-	*	-
en_1509.txt	0	29	average	JJ	(S(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	30	daily	JJ	*	-	-	-	-	*	-
en_1509.txt	0	31	hospital	NN	*	-	-	-	-	*	-
en_1509.txt	0	32	costs	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	33	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	34	Western	NNP	(NP*	-	-	-	-	*	(10
en_1509.txt	0	35	Europe	NNP	*)))	-	-	-	-	*	10)
en_1509.txt	0	36	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	37	almost	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_1509.txt	0	38	ten	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	39	times	CC	*	-	-	-	-	*	-
en_1509.txt	0	40	higher	JJR	(ADJP*)	-	-	-	-	*	-
en_1509.txt	0	41	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1509.txt	0	42	€	SYM	(X(X*)	-	-	-	-	*	-
en_1509.txt	0	43	310	CD	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	44	versus	IN	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	45	€	SYM	*	-	-	-	-	*	-
en_1509.txt	0	46	32	CD	*))))	-	-	-	-	*	-
en_1509.txt	0	47	-RRB-	-RRB-	*))))))	-	-	-	-	*	-
en_1509.txt	0	48	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Other	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1509.txt	0	1	costs	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	2	include	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	ambulatory	JJ	(NP(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	4	care	NN	*)	-	-	-	-	*	-
en_1509.txt	0	5	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1509.txt	0	6	€	SYM	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	7	9.2	CD	*	-	-	-	-	*	-
en_1509.txt	0	8	billion	CD	*))	-	-	-	-	*	-
en_1509.txt	0	9	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_1509.txt	0	10	,	,	*	-	-	-	-	*	-
en_1509.txt	0	11	drug	NN	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	12	supplies	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	13	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1509.txt	0	14	€	SYM	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	15	6.7	CD	*	-	-	-	-	*	-
en_1509.txt	0	16	billion	CD	*))	-	-	-	-	*	-
en_1509.txt	0	17	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_1509.txt	0	18	,	,	*	-	-	-	-	*	-
en_1509.txt	0	19	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	20	mortality	NN	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	21	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	22	rehabilitation	NN	*)	-	-	-	-	*	-
en_1509.txt	0	23	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1509.txt	0	24	€	SYM	(ADJP(QP*	-	-	-	-	*	-
en_1509.txt	0	25	20	CD	*	-	-	-	-	*	-
en_1509.txt	0	26	billion	CD	*))	-	-	-	-	*	-
en_1509.txt	0	27	-RRB-	-RRB-	*))))	-	-	-	-	*	-
en_1509.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	The	DT	(TOP(S(NP(NP(NP*	-	-	-	-	*	(16
en_1509.txt	0	1	largest	JJS	*	-	-	-	-	*	-
en_1509.txt	0	2	single	JJ	*	-	-	-	-	*	-
en_1509.txt	0	3	cost	NN	*)	-	-	-	-	*	-
en_1509.txt	0	4	by	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	5	far	RB	(ADVP*)))	-	-	-	-	*	-
en_1509.txt	0	6	,	,	*	-	-	-	-	*	-
en_1509.txt	0	7	estimated	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	8	at	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	9	€	SYM	(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	10	48.3	CD	*	-	-	-	-	*	-
en_1509.txt	0	11	billion	CD	*))))	-	-	-	-	*	-
en_1509.txt	0	12	,	,	*)	-	-	-	-	*	16)
en_1509.txt	0	13	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	14	indirect	JJ	(ADJP*)	-	-	-	-	*	-
en_1509.txt	0	15	:	:	*	-	-	-	-	*	-
en_1509.txt	0	16	lost	VBN	(NP*	-	-	-	-	*	-
en_1509.txt	0	17	productivity	NN	*))	-	-	-	-	*	-
en_1509.txt	0	18	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	1	total	JJ	*	-	-	-	-	*	-
en_1509.txt	0	2	number	NN	*)	-	-	-	-	*	-
en_1509.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	4	workdays	NNS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	5	lost	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	6	due	JJ	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	to	TO	*	-	-	-	-	*	-
en_1509.txt	0	8	respiratory	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	9	diseases	NNS	*))))))	-	-	-	-	*	-
en_1509.txt	0	10	was	VBD	(VP*	-	-	-	-	*	-
en_1509.txt	0	11	66.2	CD	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	12	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	13	100,000	CD	(NP(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	14	inhabitants	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	15	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	16	Western	NNP	(NP*	-	-	-	-	*	-
en_1509.txt	0	17	Europe	NNP	*)))	-	-	-	-	*	-
en_1509.txt	0	18	-	:	*	-	-	-	-	*	-
en_1509.txt	0	19	more	JJR	(ADJP(ADJP(QP*	-	-	-	-	*	-
en_1509.txt	0	20	than	IN	*	-	-	-	-	*	-
en_1509.txt	0	21	four	CD	*	-	-	-	-	*	-
en_1509.txt	0	22	times	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	23	higher	JJR	*)	-	-	-	-	*	-
en_1509.txt	0	24	than	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	25	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	26	rate	NN	*)	-	-	-	-	*	-
en_1509.txt	0	27	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	28	15.4	CD	(NP*))	-	-	-	-	*	-
en_1509.txt	0	29	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	30	Central	NNP	(NP(NP*)	-	-	-	-	*	(15)
en_1509.txt	0	31	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	32	Eastern	NNP	(NP*	-	-	-	-	*	(0
en_1509.txt	0	33	Europe	NNP	*))))))))))	-	-	-	-	*	0)
en_1509.txt	0	34	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	As	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1509.txt	0	1	with	IN	(PP(PP*	-	-	-	-	*	-
en_1509.txt	0	2	hospital	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	3	stays	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	4	,	,	*	-	-	-	-	*	-
en_1509.txt	0	5	so	RB	*	-	-	-	-	*	-
en_1509.txt	0	6	with	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	workdays	NNS	(NP*))))	-	-	-	-	*	-
en_1509.txt	0	8	:	:	*	-	-	-	-	*	-
en_1509.txt	0	9	higher	JJR	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	10	productivity	NN	*)	-	-	-	-	*	-
en_1509.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	12	Western	NNP	(NP*	-	-	-	-	*	(10
en_1509.txt	0	13	Europe	NNP	*)))	-	-	-	-	*	10)
en_1509.txt	0	14	compounds	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	15	the	DT	(NP*	-	-	-	-	*	(16
en_1509.txt	0	16	cost	NN	*))	-	-	-	-	*	16)
en_1509.txt	0	17	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Because	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_1509.txt	0	1	lung	NN	(S(NP*	-	-	-	-	*	-
en_1509.txt	0	2	diseases	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	3	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	4	so	RB	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	5	important	JJ	*))))	-	-	-	-	*	-
en_1509.txt	0	6	,	,	*	-	-	-	-	*	-
en_1509.txt	0	7	preventive	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	8	measures	NNS	*	-	-	-	-	*	-
en_1509.txt	0	9	,	,	*	-	-	-	-	*	-
en_1509.txt	0	10	early	JJ	*	-	-	-	-	*	-
en_1509.txt	0	11	detection	NN	*	-	-	-	-	*	-
en_1509.txt	0	12	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	13	treatment	NN	*)	-	-	-	-	*	-
en_1509.txt	0	14	must	MD	(VP*	-	-	-	-	*	-
en_1509.txt	0	15	be	VB	(VP*	-	-	-	-	*	-
en_1509.txt	0	16	reinforced	VBN	(VP*)))	-	-	-	-	*	-
en_1509.txt	0	17	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_1509.txt	0	1	will	MD	(VP*	-	-	-	-	*	-
en_1509.txt	0	2	necessitate	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	3	not	RB	(CONJP*	-	-	-	-	*	-
en_1509.txt	0	4	only	RB	*)	-	-	-	-	*	-
en_1509.txt	0	5	improvements	NNS	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	7	direct	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	8	patient	NN	*	-	-	-	-	*	-
en_1509.txt	0	9	care	NN	*)))	-	-	-	-	*	-
en_1509.txt	0	10	,	,	*	-	-	-	-	*	-
en_1509.txt	0	11	but	CC	(PP(CONJP*	-	-	-	-	*	-
en_1509.txt	0	12	also	RB	*)	-	-	-	-	*	-
en_1509.txt	0	13	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	14	basic	JJ	(NP(ADJP*	-	-	-	-	*	-
en_1509.txt	0	15	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	16	clinical	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	17	research	NN	*))	-	-	-	-	*	-
en_1509.txt	0	18	as	RB	(CONJP*	-	-	-	-	*	-
en_1509.txt	0	19	well	RB	*	-	-	-	-	*	-
en_1509.txt	0	20	as	IN	*)	-	-	-	-	*	-
en_1509.txt	0	21	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	22	teaching	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	23	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	24	training	NN	*)))))	-	-	-	-	*	-
en_1509.txt	0	25	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Across	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1509.txt	0	1	Europe	NNP	(NP*))	-	-	-	-	*	(0)
en_1509.txt	0	2	,	,	*	-	-	-	-	*	-
en_1509.txt	0	3	there	EX	(NP*)	-	-	-	-	*	-
en_1509.txt	0	4	are	VBP	(VP*	-	-	-	-	*	-
en_1509.txt	0	5	huge	JJ	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	6	differences	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	7	in	IN	(PP(PP*	-	-	-	-	*	-
en_1509.txt	0	8	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	9	number	NN	*)	-	-	-	-	*	-
en_1509.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	11	specialists	NNS	(NP*))	-	-	-	-	*	-
en_1509.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	13	respiratory	JJ	(NP*	-	-	-	-	*	-
en_1509.txt	0	14	medicine	NN	*))))	-	-	-	-	*	-
en_1509.txt	0	15	,	,	*	-	-	-	-	*	-
en_1509.txt	0	16	as	RB	(CONJP*	-	-	-	-	*	-
en_1509.txt	0	17	well	RB	*	-	-	-	-	*	-
en_1509.txt	0	18	as	IN	*)	-	-	-	-	*	-
en_1509.txt	0	19	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	20	the	DT	(NP(NP*	-	-	-	-	*	(17
en_1509.txt	0	21	number	NN	*)	-	-	-	-	*	-
en_1509.txt	0	22	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	23	researchers	NNS	(NP*))	-	-	-	-	*	-
en_1509.txt	0	24	at	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	25	the	DT	(NP*	-	-	-	-	*	(18
en_1509.txt	0	26	university	NN	*	-	-	-	-	*	-
en_1509.txt	0	27	level	NN	*)))))))	-	-	-	-	*	17)|18)
en_1509.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	The	DT	(TOP(S(S(NP(NP*	-	-	-	-	*	(17
en_1509.txt	0	1	number	NN	*)	-	-	-	-	*	-
en_1509.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	3	chest	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	4	physicians	NNS	*))	-	-	-	-	*	-
en_1509.txt	0	5	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	6	100,000	CD	(NP*	-	-	-	-	*	-
en_1509.txt	0	7	inhabitants	NNS	*)))	-	-	-	-	*	17)
en_1509.txt	0	8	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	9	only	RB	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	10	0.8	CD	*)	-	-	-	-	*	-
en_1509.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	12	the	DT	(NP*	-	-	-	-	*	(14
en_1509.txt	0	13	UK	NNP	*)))))	-	-	-	-	*	14)
en_1509.txt	0	14	,	,	*	-	-	-	-	*	-
en_1509.txt	0	15	but	CC	*	-	-	-	-	*	-
en_1509.txt	0	16	10.4	CD	(S(NP*)	-	-	-	-	*	-
en_1509.txt	0	17	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	18	Greece	NNP	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	19	,	,	*	-	-	-	-	*	-
en_1509.txt	0	20	with	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	21	a	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	22	European	JJ	*	-	-	-	-	*	-
en_1509.txt	0	23	average	NN	*)	-	-	-	-	*	-
en_1509.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	25	3.2	CD	(NP*)))))))	-	-	-	-	*	-
en_1509.txt	0	26	.	.	*	-	-	-	-	*	-
en_1509.txt	0	27	The	DT	(S(NP*	-	-	-	-	*	-
en_1509.txt	0	28	same	JJ	*)	-	-	-	-	*	-
en_1509.txt	0	29	is	VBZ	(VP(VP*	-	-	-	-	*	-
en_1509.txt	0	30	true	JJ	(ADJP*	-	-	-	-	*	-
en_1509.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	32	respiratory	JJ	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	33	medicine	NN	*)	-	-	-	-	*	-
en_1509.txt	0	34	at	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	35	the	DT	(NP(NP*	-	-	-	-	*	(18
en_1509.txt	0	36	university	NN	*	-	-	-	-	*	-
en_1509.txt	0	37	level	NN	*)	-	-	-	-	*	18)
en_1509.txt	0	38	,	,	*	-	-	-	-	*	-
en_1509.txt	0	39	where	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_1509.txt	0	40	the	DT	(S(NP*	-	-	-	-	*	(12
en_1509.txt	0	41	European	JJ	*	-	-	-	-	*	-
en_1509.txt	0	42	average	NN	*)	-	-	-	-	*	12)
en_1509.txt	0	43	is	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	44	0.06	VBN	(VP*	-	-	-	-	*	-
en_1509.txt	0	45	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	46	100,000	CD	(NP*	-	-	-	-	*	-
en_1509.txt	0	47	inhabitants	NNS	*))))))))))))	-	-	-	-	*	-
en_1509.txt	0	48	,	,	*	-	-	-	-	*	-
en_1509.txt	0	49	but	CC	*	-	-	-	-	*	-
en_1509.txt	0	50	varies	VBZ	(VP*	-	-	-	-	*	-
en_1509.txt	0	51	from	IN	(PP(PP*	-	-	-	-	*	-
en_1509.txt	0	52	0.04	CD	(NP(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	53	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	54	100,000	CD	(NP*)))	-	-	-	-	*	-
en_1509.txt	0	55	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	56	Poland	NNP	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	57	,	,	*	-	-	-	-	*	-
en_1509.txt	0	58	Russia	NNP	(NP*)	-	-	-	-	*	-
en_1509.txt	0	59	,	,	*	-	-	-	-	*	-
en_1509.txt	0	60	Romania	NNP	(NP*)	-	-	-	-	*	-
en_1509.txt	0	61	,	,	*	-	-	-	-	*	-
en_1509.txt	0	62	Austria	NNP	(NP*)	-	-	-	-	*	(11)
en_1509.txt	0	63	,	,	*	-	-	-	-	*	-
en_1509.txt	0	64	Germany	NNP	(NP*)	-	-	-	-	*	-
en_1509.txt	0	65	,	,	*	-	-	-	-	*	-
en_1509.txt	0	66	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	67	the	DT	(NP*	-	-	-	-	*	(14
en_1509.txt	0	68	UK	NNP	*)))))	-	-	-	-	*	14)
en_1509.txt	0	69	to	TO	(PP*	-	-	-	-	*	-
en_1509.txt	0	70	more	JJR	(NP(NP(QP*	-	-	-	-	*	-
en_1509.txt	0	71	than	IN	*	-	-	-	-	*	-
en_1509.txt	0	72	0.08	CD	*))	-	-	-	-	*	-
en_1509.txt	0	73	per	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	74	100,000	CD	(NP*)))	-	-	-	-	*	-
en_1509.txt	0	75	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	76	Norway	NNP	(NP(NP*)	-	-	-	-	*	-
en_1509.txt	0	77	,	,	*	-	-	-	-	*	-
en_1509.txt	0	78	Finland	NNP	(NP*)	-	-	-	-	*	-
en_1509.txt	0	79	,	,	*	-	-	-	-	*	-
en_1509.txt	0	80	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	81	Ireland	NNP	(NP*))))))))	-	-	-	-	*	(13)
en_1509.txt	0	82	.	.	*))	-	-	-	-	*	-

en_1509.txt	0	0	Given	VBN	(TOP(S(PP*	-	-	-	-	*	-
en_1509.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	2	scale	NN	*)	-	-	-	-	*	-
en_1509.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	4	their	PRP$	(NP*	-	-	-	-	*	(17)
en_1509.txt	0	5	human	JJ	*	-	-	-	-	*	-
en_1509.txt	0	6	and	CC	*	-	-	-	-	*	-
en_1509.txt	0	7	economic	JJ	*	-	-	-	-	*	-
en_1509.txt	0	8	costs	NNS	*))))	-	-	-	-	*	-
en_1509.txt	0	9	,	,	*	-	-	-	-	*	-
en_1509.txt	0	10	managing	NN	(NP*	-	-	-	-	*	-
en_1509.txt	0	11	lung	NN	*	-	-	-	-	*	-
en_1509.txt	0	12	diseases	NNS	*)	-	-	-	-	*	-
en_1509.txt	0	13	should	MD	(VP*	-	-	-	-	*	-
en_1509.txt	0	14	become	VB	(VP*	-	-	-	-	*	-
en_1509.txt	0	15	a	DT	(NP(NP*	-	-	-	-	*	-
en_1509.txt	0	16	high	JJ	*	-	-	-	-	*	-
en_1509.txt	0	17	priority	NN	*)	-	-	-	-	*	-
en_1509.txt	0	18	for	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	19	all	DT	(NP*	-	-	-	-	*	(4
en_1509.txt	0	20	European	JJ	*	-	-	-	-	*	-
en_1509.txt	0	21	countries	NNS	*))	-	-	-	-	*	4)
en_1509.txt	0	22	in	IN	(PP*	-	-	-	-	*	-
en_1509.txt	0	23	the	DT	(NP*	-	-	-	-	*	-
en_1509.txt	0	24	twenty-first	JJ	*	-	-	-	-	*	-
en_1509.txt	0	25	century	NN	*)))))	-	-	-	-	*	-
en_1509.txt	0	26	.	.	*))	-	-	-	-	*	-

#end document
